Welcome to the first issue of Retina Today Business Matters for 2021. Hopefully the trials of 2020 are behind us, although face masks, face shields, and disinfecting wipes may be permanent line items in our budgets now.
Unfortunately, 2020 put a lot of emotional and financial strain on practice owners. It had a lot of us asking, “Is it time to get out?”
Many, like this month’s featured author, decided it was time to hand over their practice management responsibilities to a private equity (PE) firm and shift their focus back to patient care. In his article, “Making the Leap to Private Equity,” David F. Williams, MD, MBA, details the pros and cons of the decision to sell to PE, and why merging with a firm consisting only of retina practices made all the difference for him and his partners.
It’s a big decision, and one many practice owners are still leery about. As PE investors continue to consolidate ophthalmology practices, now is a good time to revisit the subject and see how the landscape has changed, and why it may—or may not—be the right move for your practice.
For those of you who aren’t interested in PE, this issue also includes articles geared toward growing your practice and improving your revenue streams. You can learn about a four-step process for embracing growth opportunities safely, how to capitalize on today’s historically low interest rates, and how to improve your reimbursements for same-session procedures.
Regardless of whether you are looking for an escape route in 2021 or are looking for ways to make this your practice’s best year yet, we’ve got you covered.
Alan Ruby, MD
SECTION Editor
